Mater Research is a recognised leader in medical research. Our bench to bedside philosophy sees us working across Mater Health’s hospitals and health services, The University of Queensland, and the world-class Translational Research Institute (TRI). We are committed to working closely with Mater Health, Mater Education and our growing network of partners and collaborators to turn scientific discovery into the best possible treatment, care, and outcomes for patients and our broader community. 

Our key focus areas are Cancer biology and care , Chronic disease biology and care , Implementing evidence to improve health , Mothers', babies and women's health , Neurosciences and cognitive health , Optimising acute care .

Immune infiltration 'promising tool' to improve outcomes for follicular lymphoma
In a paper published today in the Journal of Clinical Oncology, Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with follicular lymphoma.
International spotlight on newborn care
Mater’s strong focus on family-integrated care—involving parents in the care of their babies—was a feature of Professor Helen Liley’s address to the prestigious Boston Children’s Hospital (BCH) 150th Anniversary event held this month.
Mater Research CEO appointed to new National Blood Cancer Taskforce
Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for Blood Cancer.
Latest News

Professor Brian Gabrielli and team seek out the to answer a question—what is broken in melanomas that allows the damage to accumulate rather...

02

Dec

New light in melanoma research

Mater Hospital is leading the way in cutting-edge health and medical research at the Research Australia Awards.

27

Nov

Mater Shines at Research Australia Awards

Collaboration between clinical research institutes the Griffith Institute for Drug Discovery, Mater Research and Translational Research...

25

Nov

Brisbane Based Breakthrough in Cancer Research

The Annual Mater Research Awards and Young Investigator Symposium has been held in Brisbane this week recognising the significant contribution...

21

Nov

Mater Research Awards and Young Investigator Symposium

Mater Researcher Dr Felicity Davis has been awarded one of two $50,000 Metcalf Prizes from the National Stem Cell Foundation of Australia.

05

Nov

Dr Felicity Davis awarded Metcalf prize

A new spin-out from The University of Queensland will develop a novel therapy for the growing problem of obesity-related liver disease with...

30

Oct

MRI-UQ discoveries translated from the lab into a spin-out company with real-world application

Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National...

04

Sep

Mater Research CEO appointed to new National Blood Cancer Taskforce

Mater researcher Dr Vicki Clifton and Mater Centre for Neuroscience’s Dr Lisa Gillinder have been recognised for their achievements at the...

02

Sep

Mater researchers recognised at Women in Technology awards

Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve...

29

Aug

Immune infiltration 'promising tool' to improve outcomes for follicular lymphoma

A vaccine for childhood respiratory viral infections is a step closer after an Mater Research Institute—UQ immunopathology specialist was...

22

Jul

RSV vaccine a step closer